Sodium Tetradecyl Sulfate

Description

Sodium Tetradecyl Sulfate is used for the treatment of uncomplicated varicose veins in the legs, a condition where the veins become large, twisted and swollen when the vein valves do not work properly. This medicine is not recommended for use in patients less than 18 years of age.

Side effects

Major & minor side effects for Sodium Tetradecyl Sulfate

  • Shortness of breath
  • Cough
  • Blurred vision
  • Chest pain or discomfort
  • Fast heartbeat
  • Nausea and vomiting
  • Severe headache

Uses of Sodium Tetradecyl Sulfate

What is it prescribed for?

  • Varicose veins
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required for this medicine to show its action is not clinically established.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to Sodium Tetradecyl Sulfate or any other inactive ingredients present along with it.

Thrombophlebitis

This medicine is not recommended for use in patients suffering from Thrombophlebitis (a condition of inflammation of veins) due to the increased risk of worsening of the patient's condition.

Uncontrolled systemic diseases

This medicine is not recommended for use in patients with uncontrolled systemic diseases as diabetes, hyperthyroidism, tuberculosis, asthma, neoplasm, sepsis, blood dyscrasias and acute respiratory or skin diseases due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Bedridden patients

This medicine is not recommended for use in bedridden patients or patients unable to walk due to any cause. Replacement with a suitable alternative may be necessary based on the clinical condition.

Varicosities caused by tumors

This medicine is not recommended for use in patients with varicosities caused by a pelvic tumor or abdominal tumor unless the tumor has been removed.

Anaphylactic shock

A small dose of 0.5 ml of this medicine should be injected into varicosity and the patient have to be observed for several hours for signs of allergic reactions especially anaphylactic shock. Appropriate corrective treatments should be readily available in any such cases of allergic reactions.

Migraine

A small dose of this medicine has to be administered to patients with a migraine due to the risk of adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Extravasation

This medicine has to be administered very carefully to avoid extravasation, as this can cause severe tissue necrosis.

Use in Children

This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

Missed Dose

Since this medicine is administered by a qualified health care professional in the clinical or hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified health care professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine increases the formation of blood clots and scar tissue inside the veins and thus immediately helps to shrink the enlarged veins.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Sclerosing agents

Schedule

Schedule H

DailyMed - SOTRADECOL- tetradecyl hydrogen sulfate (ester) injection, solution [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 7 September 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1756c28-dcd2-4b49-be62-07ca20682018&audience=consumer

Fibrovein 0.5% - Summary of Product Characteristics (SmPC) - (eMC) [Internet]. Medicines.org.uk. 2018 [cited 7 September 2018]. Available from:

https://www.medicines.org.uk/emc/product/7534/smpc

Fibrovein 3% - Summary of Product Characteristics (SmPC) - (eMC) [Internet]. Medicines.org.uk. 2018 [cited 7 September 2018]. Available from:

https://www.medicines.org.uk/emc/product/1199/smpc

Sodium Tetradecyl Sulfate - DrugBank [Internet]. Drugbank.ca. 2018 [cited 7 September 2018]. Available from:

https://www.drugbank.ca/drugs/DB00464

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 11 Jun 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.